A POPULATION PHENOTYPING STUDY ON SIX (FIVE) DRUG-METABOLIZING ENZYMES AND THE THERAPEUTIC RELEVANCE.
A POPULATION PHENOTYPING STUDY ON SIX (FIVE) DRUG-METABOLIZING ENZYMES AND THE THERAPEUTIC RELEVANCE.
批准号:
11672267
负责人:
ISHIZAKI Takashi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Aim #1 : We determined whether the two probe drugs, caffeine and phenytoin, could be simultaneously administered as a cocktail test to estimate three cytochromes P450 (CYP1A2, 2C9 and 2C19), N-acetyltransferase (NAT2), xanthine oxidase (XO) and flavin-containing monooxygenase (FMO) enzyme activities in vivo. in 1999.Methods : Twenty-nine healthy volunteers (14 men and 15 women) received orally 150 mg of caffeine and 100 mg of phenytoin separately and in combination using a 3x3 Latin square. The activities of CYP1A2, NAT2 and XO were expressed by urinary caffeine metabolic ratios, and those of CYP2C9 and 2C19 by phenytoin chiral metabolite ratios.Results : Ascertaining the separate and cocktail phenotyping tests for caffeine correlated with each other, but that for phenytoin did not.Aim #2 : Based on the results of Aim #1, caffeine phenotyping test was extended to assess in vivo activities of five drug-metabolizing enzymes, CYP1A2, NAT2, XO, FMO and CYP2A6 in Kyushu, Japan, in 2000.Methods : One hundred eighty-two healthy volunteers (108 men and 74 women) received an oral 150-mg dose of caffeine before sleep, then overnight urine sample was collected and the concentrations of caffeine and its metabolites were analyzed by HPLC.The enzyme activities were expressed by urinary caffeine metabolic ratios.Results : Frequency distributions of CYP1A2, FMO, and CYP2A6 activities were unimodal, whereas those of NAT2, and XO activities were trimodal and bimodal, respectively. The CYP1A2 activity was statistically higher in smokers than in non-smokers (p<0.0001). The frequency of slow acetylators was 11%. The activities of CYP1A2 and XO were statistically higher (p<0.01), and that of NAT2 was lower (p<0.02) in males than in females. A few subjects showed significantly low activities of CYP1A2, XO, FMO, and CYP2A6. We are currently determining the genotypes of these enzymes and will determine the therapeutic relevance.
期刊论文(83)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hamaoka N, et al.: "Propofol decreases the clearance of midazolm by inhibiting CYP3A4 : An in vivo and in vitro study."Clin Pharmacol Ther. 66. 110-117 (1999)
Hamaoka N 等人:“异丙酚通过抑制 CYP3A4 降低咪达唑姆的清除率:一项体内和体外研究。”Clin Pharmacol Ther。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
石崎高志,越前宏俊,古家恵子: "薬物の副作用と相互作用:(多賀須幸男ら編集)今日の治療指針2000"医学書院、東京. 1159-1280 (2000)
Takashi Ishizaki、Hirotoshi Echizen、Keiko Furuya:“药物副作用和相互作用:(由 Yukio Tagasu 等编辑)今日治疗指南 2000”Igakushoin,Tokyo 1159-1280 (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Zhao X-J and Ishizaki T.: "A further interaction study of quinine with clinically important studs by human liver microsomes : Determinations of inhibition constant (ki) and type of inhibition."Eur J Drug Metab Pharmacokinet. 24. 272-278 (1999)
赵X-J和石崎T.:“通过人肝微粒体进行奎宁与临床重要研究的进一步相互作用研究:抑制常数(ki)和抑制类型的测定。”Eur J Drug Metab Pharmacokinet。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kudo S and Ishizaki T.: "Pharmacokinetics of haloperidol : An update."Clin Pharmacokinet. 37. 435-456 (1999)
Kudo S 和 Ishizaki T.:“氟哌啶醇的药代动力学:更新。”Clin Pharmacokinet。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Marcus PM, et al.: "Cigarette smoking, N-acetyltransferase 2 acetylation status, and bladder cancer risk : A case-series meta-analysis of a gene-environmentinteractio Cancer Epidemiology"Biomarkers & Prevention. 9. 461-467 (2000)
Marcus PM 等人:“吸烟、N-乙酰转移酶 2 乙酰化状态和膀胱癌风险:基因-环境相互作用癌症流行病学的病例系列荟萃分析”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 68 条
Verification of the L1 and L2 information processing model using a computer-controlled verbal-response Stroop test
-
批准号:17K02965
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2017
-
负责人:ISHIZAKI Takashi
-
依托单位:
Development of a computer-controlled verbal-response Stroop test
-
批准号:23652129
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:ISHIZAKI Takashi
-
依托单位:
国内基金
海外基金
大鱼际掌纹特应征与5个哮喘易感基因单核苷酸多态性的关联分析
-
批准号:30873315
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2008
-
负责人:周兆山
-
依托单位: